Skip to main content

Table 1 Baseline characteristics and final diagnoses in a randomized population

From: Virtual bronchoscopic navigation without X-ray fluoroscopy to diagnose peripheral pulmonary lesions: a randomized trial

 

VBNA group

(n = 65)

XRFA group

(n = 64)

P-value

Age (y, median; range)

71 [48–86]

70.5 [53–84]

0.794

Male, n (%)

46 (70.8)

52 (81.3)

0.217

Lesion size

(mm, median; range)

37.5

[30–97]

39.0

[30–84]

0.823

  ≤ 50 mm, n (%)

49 (75.4)

55 (85.9)

0.181

Lesion location

  

0.313

 Rt. upper lobe, n (%)

19 (29.2)

14 (21.9)

 

 Rt. middle lobe, n (%)

5 (7.7)

2 (3.1)

 

 Rt. lower lobe, n (%)

13 (20.0)

19 (29.7)

 

 Lt. upper lobe, n (%)

21 (32.3)

17 (26.6)

 

 Lt. lower lobe, n (%)

7 (10.8)

12 (18.8)

 

Final diagnosis

  

0.090

 Primary lung cancer, n (%)

56 (86.2)

60 (93.8)

 

 Other malignant diseases, n (%)

3 (4.6)

2 (3.1)

 

 Non-malignant disease, n (%)

6 (9.2)

2 (3.1)

 

Frontal X-ray film

  

0.493

 Invisible

2 (3.1)

3 (4.7)

 

 Visible

63 (96.9)

61 (95.3)

 

Bronchus sign

  

0.119

 Absent

0 (0)

3 (4.7)

 

 Present

65 (100)

61 (95.3)

 

Location

  

0.345

 Central

7 (10.8)

4 (6.3)

 

 Intermediate

11 (16.9)

17 (26.6)

 

 Peripheral

47 (72.3)

43 (67.2)

Â